SEATTLE & CAMBRIDGE, Mass. & TOKYO–(BUSINESS WIRE)–Aurion Biotech, whose mission is to restore vision to millions of patients with life-changing regenerative therapies, today announced that CEO Greg Kunst has been named winner of the Ernst & Youn…
Author: Business Wire
Bausch + Lomb Announces Presentation of New Data at the European Dry Eye Society 2024 Congress
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the presentation of several scientific presentations and education…
Glaukos Announces Agreements to Exchange $230 Million in Principal Amount of Its 2.75% Convertible Senior Notes Due 2027 for Common Stock
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company, today announced that it entered into separate, privately negotiated exchange agreements (the “Exchange Agreements”) wit…
EyeCare Partners Strengthens Executive Leadership Team with New Appointments
ST. LOUIS–(BUSINESS WIRE)–EyeCare Partners, the nation’s leading provider of clinically integrated eye care, announced today new additions, bolstering its executive leadership team by adding strengthened and integrated capabilities that build on the …
Aldeyra Therapeutics Completes Enrollment in Phase 3 Clinical Trial of Reproxalap in Dry Eye Disease
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced the com…
Global Brain and Vision Research Nonprofit to Host Inaugural Concert for Cures Celebrating Science
CLARKSBURG, Md.–(BUSINESS WIRE)–Global brain and vision research nonprofit BrightFocus Foundation will host its inaugural Concert for Cures benefit on June 26 in Nashville.
Fortress Announces £750 million Forward Flow Agreement to Support the Continued Growth of Tabeo, the UK’s Largest Provider of Retail Finance for Primary Care Providers
NEW YORK & DALLAS–(BUSINESS WIRE)–Fortress today announced the completion of a £750 million forward flow agreement with Tabeo, the largest provider of retail finance for primary care providers in the UK. The new debt financing with funds managed by a…
Pennsylvania Employees Benefit Trust Fund (PEBTF) Enhances Health Benefits for Commonwealth of Pennsylvania Employees Enrolled in the PEBTF
HARRISBURG, Pa.–(BUSINESS WIRE)–The Board of Trustees of the Pennsylvania Employees Benefit Trust Fund (PEBTF) today announced enhancements to the current Plan of Benefits for employees and their eligible dependents. Effective August 1, 2024, employe…
From the Eye to the Brain: World’s Top Scientists Gather in Rome to Discuss Future of Neurotrophins in Eye and Brain Research
ROME–(BUSINESS WIRE)– #biotech–Nature Conferences has convened a meeting of leading global scientists to discuss the state of the art and future lines of research on neurotrophins. The event, From the Eye to the Brain, will focus on the potential ne…
Viridian Therapeutics Announces Details of Subcutaneous VRDN-003 Phase 3 Clinical Program for Patients with Active and Chronic Moderate-to-Severe Thyroid Eye Disease
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today reported details of its plans to initiate …
Bausch + Lomb INFUSE® for Astigmatism Silicone Hydrogel Daily Disposable Contact Lenses Introduced in the United States
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. introduction of Bausch + Lomb INFUSE for Astigmatism dail…
NovaBay Pharmaceuticals Plan of Compliance Accepted by the NYSE American
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) (the “Company”) announces that the NYSE American LLC (“NYSE American”) has accepted the Company’s plan to regain compliance with NYSE American’s continued listing …
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN) (the “company” or “Viridian”), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announce…
Melt Pharmaceuticals Announces First Patient Dosed in Pivotal Phase 3 Program of Its Lead Product Candidate, MELT-300, for Needle- and Opioid-Free Sedation in Patients Undergoing Cataract Surgery
NASHVILLE, Tenn.–(BUSINESS WIRE)–Melt Pharmaceuticals, Inc. (“Melt”), a clinical-stage pharmaceutical company developing novel approaches for procedural sedation, today announced that the first patient has been dosed in its Phase 3 program evaluating…
Verséa Health, Inc. Acquires ISO 9001 Certification
TAMPA, Fla.–(BUSINESS WIRE)– #ISO9001–Verséa Health, Inc. (“Verséa”), a Florida-based transformative health care company specializing in the commercialization of innovative diagnostics, therapeutics, and health services, has successfully acquired th…
Mississippi Retina Associates: Revolutionizing Retinal Care
MADISON, Miss.–(BUSINESS WIRE)– #innovation–Mississippi Retina Associates’ Retina Research Institute, has successfully performed the state’s first retina-specific gene therapy surgery.
Harrow Announces 52-Week Data from VEVYE® ESSENCE-2 Open-Label Extension Study
NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, is pleased to announce results from its ESSENCE‑2 open-label extension (OLE) clinical study for VEVYE® (cyclosporine ophthalmic…
STAAR Surgical to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, invites investors and the g…
Heru Prime Diagnostic Platform Showcased at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting held in Seattle, Garnering Praise for Exceptional Diagnostic Performance
MIAMI–(BUSINESS WIRE)–Heru Inc., in collaboration with the Bascom Palmer Eye Institute, presented outstanding clinical data in four clinical studies at the ARVO meeting in Seattle, highlighting Heru Prime’s exceptional diagnostic capabilities. Heru i…
National Vision Expands Access to Affordable Eye Care and Eyewear with Opening of 1,000th America’s Best Store
PHILADELPHIA–(BUSINESS WIRE)–National Vision, Inc., one of the nation’s largest optical retailers, is celebrating a major milestone with the opening of its 1,000th America’s Best store, located in South Philadelphia. The achievement represents a cont…